ArticleScientific reports2025
QKDTI A quantum kernel based machine learning model for drug target interaction prediction.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- A Narrative Review of Artificial Intelligence for Drug Repurposing: Lessons From COVID-19 and Oncology (2020-2025).CPT: pharmacometrics & systems pharmacology · 2026Review
- Quantum Angle-distance kernel for ECG classification and anomaly detection: a quantum-inspired framework for biomedical signal analysis.BioData mining · 2026Article
- Quantum-machine-assisted drug discovery.npj drug discovery · 2026Review
- Recent advances in computational antimicrobial peptide discovery through big data, modeling, and artificial intelligence and their interplay in ushering the next golden era of drug development.Frontiers in bioinformatics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Drug-target interaction (DTI) prediction is a critical task in computational drug discovery, enabling drug repurposing, precise medicine, and large-scale virtual screening. Traditional in-silico methods, such as molecular docking, classical machine learning, and deep learning, have made significant progress in addressing this issue. However, existing approaches are hindered by computational inefficiencies, reliance on manual feature engineering, and struggles to generalize across diverse molecular structures, limiting their molecular capabilities. Recent advancements in Quantum Machine Learning (QML) are paving the way for its practical applications, unlocking unprecedented capabilities in predictive accuracy, scalability, and efficiency by leveraging the unique powers of quantum computing, namely superposition and entanglement. This study proposes QKDTI - Quantum Kernel Drug-Target Interaction, a novel quantum-enhanced framework for DTI prediction. It used Quantum Support Vector Regression (QSVR) with quantum feature mapping that takes into account a quantum feature space for molecular descriptors and allows encoding molecular and protein features, improved predictions of binding affinities. To enhance the model to be more computationally feasible, integration of the Nystrom approximation into the model allows providing an efficient kernel approximation while reducing overhead expenses. QKDTI was evaluated on benchmark datasets - Davis and KIBA, and validated independently on BindingDB. This model achieves 94.21% accuracy on DAVIS, 99.99% on KIBA, and 89.26% on BindingDB, significantly outperforming classical and other quantum models. Further, the statistical tests have been conducted on the compared models to provide the reliability of the results. This indicates that introducing quantum computing into DTI pipeline can revolutionize computational drug discovery by improving predictive accuracy and providing a better generalization over multiple datasets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.